| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.2 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |